Skip to main content
. 2023 Sep 18;15(9):2337. doi: 10.3390/pharmaceutics15092337

Figure 10.

Figure 10

Schematic illustration of fabrication of the pro-ferroptotic Fe(III)PP@SAS NPs and their therapeutic mechanism [88].